Stock CUBT CURATIVE BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Curative Biotechnology, Inc.

Equities

CUBT

US23128N2071

Delayed OTC Markets
Other stock markets
 17:25:50 02/07/2024 BST 		5-day change 1st Jan Change
0.0138 USD -5.78% Intraday chart for Curative Biotechnology, Inc. -12.03% -34.74%
2021 Curative Biotechnology, Inc. Appoints Marc Drimer to Board of Directors as Independent Director and Chairman of Audit Committee CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors
PR
Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration
PR
Curative Biotechnology Announces Cooperative Research and Development Agreement(CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration
PR
Curative Biotechnology : Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine
PR
Curative Biotechnology : Appoints Marc Drimer, CPA to Board of Directors as Independent Director and Chairman of Audit Committee
AQ
Choroideremia Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | 4D Molecular Therapeutics, Roche, Biogen and Many Others
AQ
Curative Biotechnology, Inc. Files 2021 First Quarter Financials and Issues Letter to Shareholders
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CUBT Stock
  4. News Curative Biotechnology, Inc.
  5. Press Releases